Flexion Therapeutics Inc. (FLXN) Jumps 5.87% on February 10

Equities Staff |

Flexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Wednesday February 10 as the stock popped 5.87% to $11.90, representing a gain of $0.66 per share. Some 171,093 shares traded hands on 1,135 trades, compared with an average daily volume of 168,820 shares out of a total float of 21.54 million. The stock opened at $11.25 and traded with an intraday range of $12.24 to $11.14.

After today's gains, Flexion Therapeutics Inc. reached a market cap of $256.32 million. Flexion Therapeutics Inc. has had a trading range between $30.37 and $10.87 over the last year, and it had a 50-day SMA of $17.22 and a 200-day SMA of $19.60.

Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including; anti-inflammatory and analgesic therapies.

Flexion Therapeutics Inc. is based out of Burlington, MA and has some 29 employees. Its CEO is Michael D. Clayman.

For a complete fundamental analysis analysis of Flexion Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for FLXN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.